Panelists discuss how identifying type 2 inflammation in patients influences treatment decisions by steering clinicians toward targeted therapies, such as biologics or other immunomodulators, that ...

(BPT) – Do you live with persistent, moderate-to-severe asthma, COPD, allergies, eczema or hives? Inflammation is often a major factor in the severity of your symptoms. It could also be a factor if ...

Panelists discuss how biomarkers of type 2 inflammation, such as blood eosinophils, serum IgE, and fractional exhaled nitric oxide, can aid in diagnosing and monitoring type 2 inflammatory diseases as ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients receiving mepolizumab vs. placebo had a smaller ...

A GSK drug that targets a pathway behind the lung inflammation in chronic obstructive pulmonary disease, or COPD, has won a long-awaited FDA approval, positioning the biologic medicine to reach ...

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

Two weeks of an intensive diabetes treatment has shown promise in improving periodontal disease inflammation among patients with type 2 diabetes. The corresponding study was published in Diabetes, ...

Obesity, inflammation, and type 2 diabetes are interconnected in a cyclical way. Obesity causes chronic inflammation, which helps drive the development and progression of type 2 diabetes. Diabetes, in ...